AMG 176 exhibits robust antitumor activity in combination with standard of care agents in models of acute myeloid leukemia

被引：0
|
作者：
Caenepeel, Sean [1 ]
Belmontes, Brian [1 ]
Osgood, Tao [1 ]
Cajulis, Elaina [1 ]
Coxon, Angela [1 ]
Canon, Jude [1 ]
Hughes, Paul E. [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-2180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2180
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy of AMG 176 in combination with gilteritinib in preclinical models of acute myeloid leukemia.
    Chen, Xiaoyue
    Caenepeel, Sean
    Belmontes, Brian
    McElroy, Patricia L.
    Rex, Karen
    Osgood, Tao
    Hughes, Paul
    CANCER RESEARCH, 2021, 81 (13)
  • [2] MDM2 inhibitor APG-115 exerts potent antitumor activity and synergizes with standard-of-care agents in preclinical acute myeloid leukemia models
    Douglas D. Fang
    Qiuqiong Tang
    Yanhui Kong
    Tao Rong
    Qixin Wang
    Na Li
    Xu Fang
    Jiaxing Gu
    Dengkun Xiong
    Yan Yin
    Jing Deng
    Dajun Yang
    Yifan Zhai
    Cell Death Discovery, 7
  • [3] MDM2 inhibitor APG-115 exerts potent antitumor activity and synergizes with standard-of-care agents in preclinical acute myeloid leukemia models
    Fang, Douglas D.
    Tang, Qiuqiong
    Kong, Yanhui
    Rong, Tao
    Wang, Qixin
    Li, Na
    Fang, Xu
    Gu, Jiaxing
    Xiong, Dengkun
    Yin, Yan
    Deng, Jing
    Yang, Dajun
    Zhai, Yifan
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [4] Antitumor activity of bortezomib alone and in combination with trail in human acute myeloid leukemia
    Conticello, Concetta
    Adamo, Luana
    Vicari, Luisa
    Giuffrida, Raffaella
    Iannolo, Gioacchin
    Anastasi, Gabriele
    Caruso, Laura
    Moschetti, Gaetano
    Cupri, Alessandra
    Palumbo, Giuseppe Antonio
    Gulisano, Massimo
    De Maria, Ruggero
    Giustolisi, Rosario
    Di Raimondo, Francesco
    ACTA HAEMATOLOGICA, 2008, 120 (01) : 19 - 30
  • [5] Antitumor activity of bortezomib alone and in combination with trail in human acute myeloid leukemia
    Conticello, C. M. S.
    Adamo, L.
    Vicari, L.
    Giuffrida, R.
    Iannolo, G.
    Moschetti, G.
    Anastasi, G.
    Palumbo, G. A.
    De Maria, R.
    Giustolisi, R.
    Di Raimondo, F.
    Gulisano, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 13 - 13
  • [6] Antitumor activity of Bortezomib alone and in combination with TRAIL in human acute myeloid leukemia.
    Conticello, Concetta
    Adamo, Luana
    Vicari, Luisa
    Giuffrida, Raffaella
    Iannolo, Gioacchin
    Anastasi, Gabriele
    Palumbo, Giuseppe A.
    Gulisano, Massimo
    De Maria, Ruggero
    Giustolisi, Rosario
    Di Raimondo, Francesco
    BLOOD, 2007, 110 (11) : 144B - 144B
  • [7] Venetoclax in Combination with Hypomethylating Agents Compared to Standard Chemotherapy in Relapsed/ Refractory Acute Myeloid Leukemia
    Mohassel, Leila
    Yakubi, Hanna
    Jones, Kendra
    Wang, Hongkun
    Shafer, Danielle
    BLOOD, 2022, 140 : 6158 - 6159
  • [8] Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia
    Zhang, Lu
    Cai, Tianyu
    Lin, Xiaoyu
    Huang, Xiaoli
    Bui, Mai H.
    Plotnik, Joshua P.
    Bellin, Richard J.
    Faivre, Emily J.
    Kuruvilla, Vinitha M.
    Lam, Lloyd T.
    Lu, Xin
    Zha, Zheng
    Feng, Weiguo
    Hessler, Paul
    Uziel, Tamar
    Zhang, Qi
    Cavazos, Antonio
    Han, Lina
    Ferguson, Debra C.
    Mehta, Gaurav
    Shanmugavelandy, Sriram S.
    Magoc, Terrance J.
    Rowe, Jenny
    Goodwin, Neal C.
    Dorritie, Kathleen A.
    Boyiadzis, Michael
    Albert, Daniel H.
    McDaniel, Keith F.
    Kati, Warren M.
    Konopleva, Marina
    Shen, Yu
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (10) : 1809 - 1819
  • [9] Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia
    He, Licai
    Shi, Liuzhi
    Du, Zhuanyun
    Huang, He
    Gong, Rui
    Ma, Lan
    Chen, Lianjuan
    Gao, Shenmeng
    Lyu, Jianxin
    Gu, Haihua
    EXPERIMENTAL CELL RESEARCH, 2018, 369 (01) : 61 - 68
  • [10] Relapsed acute myeloid leukemia: Why is there no standard of care?
    Ravandi, Farhad
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (03) : 253 - 259
12345